Invasive Lobular Carcinoma: Brenda's Survivor Story
This breast cancer diagnosis at a glance
- Subtype
- Invasive Lobular Carcinoma
- Sex
- Female
- Treatment
- surgery, chemotherapy, radiation, hormone therapy and targeted therapy
- Outcome
- Care Ongoing / Survivorship
Treatment course, step by step
- Mastectomy
- chemotherapy
- radiation
- oophorectomy
- ongoing anastrozole plus an unspecified CDK4/6 inhibitor.
What happened, in summary
Brenda first found a breast lump in 2017, when she was in her early 40s. She was told it was a cyst, while an area of calcification seen on mammography was monitored every 6 months for the next 5 years.
During a mammogram in May 2022, the area believed to be a cyst ruptured and caused severe pain. A week later, Brenda told her family doctor that the breast tissue felt different, but the mammogram was considered clear and another study was planned for 6 months later. As that appointment approached, Brenda returned because she wanted a different type of test. Her doctor then agreed that the breast did not look right and referred her to a specialist, who ordered a biopsy.
On November 28, 2022, Brenda learned at age 49 that she had invasive lobular carcinoma. Imaging before surgery substantially underestimated the extent of the disease. The mastectomy specimen showed a 10 cm tumor, and 6 of 8 lymph nodes contained cancer.
Brenda went on to receive chemotherapy and radiation. She also had an oophorectomy and began ongoing treatment with anastrozole and a CDK4/6 inhibitor. Connecting with other people affected by lobular breast cancer helped her feel less isolated and gave her information she could use to ask more focused questions about her care.
Where this story comes from
This is a lay summary of an account first published by Lobular Breast Cancer Alliance. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer